Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 8/20 | 0.69 |
| ▸ | TNF | P01375 | 3/20 | 0.69 |
| ▸ | ACHE | P22303 | 2/20 | 0.69 |
| ▸ | PDE4A | P27815 | 2/20 | 0.69 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.69 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.69 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.69 |
| ▸ | USP2 | O75604 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.69 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.69 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.69 |
| ▸ | CHIT1 | Q13231 | 1/20 | 0.66 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.66 |
| ▸ | GLA | P06280 | 1/20 | 0.63 |
| ▸ | BLM | P54132 | 1/20 | 0.63 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11300380 | 0.95 | ADORA2B (0.71) | ADORA2BTNFACHEPDE4APDE4B | |
| SCHEMBL8852328 | 0.94 | ADORA2B (0.70) | ADORA2BTNFACHEPDE4APDE4B | |
| SCHEMBL17682242 | 0.92 | ADORA2B (0.67) | ADORA2BTNFACHEPDE4APDE4B | |
| Bisdionin D SCHEMBL16120988 | 0.92 | ADORA2B (0.79) | ADORA2BTNFACHEPDE4APDE4B | |
| Bisdionin C SCHEMBL10018600 | 0.92 | CHIT1 (0.75) | ADORA2BTNFACHEPDE4APDE4B | |
| SCHEMBL16120981 | 0.91 | ADORA2B (0.77) | ADORA2BTNFACHEPDE4APDE4B | |
| Bisdionin B SCHEMBL29896692 | 0.89 | ADORA2B (0.74) | ADORA2BTNFACHEPDE4APDE4B | |
| SCHEMBL516018 | 0.88 | PDE4A (0.78) | ADORA2BTNFACHEPDE4APDE4B | |
| SCHEMBL5463429 | 0.88 | ADORA2B (0.68) | ADORA2BTNFACHEPDE4APDE4B | |
| SCHEMBL9293614 | 0.87 | ADORA2B (0.71) | ADORA2BTNFACHEPDE4APDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-56040685-A | — | — | None | — | — | JP | disclosed |
| JP-55062087-A | — | — | None | — | — | JP | disclosed |
| JP-55076876-A | — | — | None | — | — | JP | disclosed |
| US-20260117148-A1 | SEMICONDUCTOR TREATMENT LIQUID, TREATMENT METHOD FOR OBJECT TO BE TREATED, AND MANUFACTURING METHOD OF ELECTRONIC DEVICE | FUJIFILM CORP (JP) | 2026-04-30 | — | — | US | disclosed |
| US-20250017209-A1 | COMPOSITION, MANUFACTURING METHOD FOR SEMICONDUCTOR ELEMENT, AND CLEANING METHOD FOR SEMICONDUCTOR SUBSTRATE | FUJIFILM CORPORATION (JP) | 2025-01-16 | — | — | US | disclosed |
| US-20240400942-A1 | CLEANING COMPOSITION AND CLEANING METHOD OF SEMICONDUCTOR SUBSTRATE | FUJIFILM CORPORATION (JP) | 2024-12-05 | — | — | US | disclosed |
| CN-118922917-A | Composition, method for manufacturing semiconductor element, and method for cleaning semiconductor substrate | 富士胶片株式会社 | 2024-11-08 | — | — | CN | disclosed |
| WO-2024122300-A1 | PROCESSING LIQUID, CLEANING METHOD FOR OBJECT TO BE PROCESSED, AND METHOD FOR PRODUCING ELECTRONIC DEVICE | 富士フイルム株式会社 | 2024-06-13 | — | — | WO | disclosed |
| US-20240117278-A1 | TREATMENT LIQUID, CLEANING METHOD OF SEMICONDUCTOR SUBSTRATE, AND MANUFACTURING METHOD OF SEMICONDUCTOR ELEMENT | FUJIFILM CORPORATION (JP) | 2024-04-11 | — | — | US | disclosed |
| US-20240026254-A1 | CLEANING LIQUID FOR SEMICONDUCTOR SUBSTRATE | FUJIFILM CORPORATION (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20090270369-A1 | BICYCLOAMINE DERIVATIVES | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2009-10-29 | — | — | US | disclosed |
| WO-2009101917-A1 | BICYCLOAMINE DERIVATIVE | EISAI R & D MANAGEMENT CO., LTD. (JP) | 2009-08-20 | — | — | WO | disclosed |
| US-6686353-B1 | PREVENTING BLOOD MONOCYTES AND LYMPHOCYTES FROM INFILTRATING TISSUE | TEIJIN INTELLECTUAL PROPERTY CENTER LIMITED (JP) | 2004-02-03 | — | — | US | disclosed |
| EP-0914319-B1 | DIARYLALKYL CYCLIC DIAMINE DERIVATIVES AS CHEMOKINE RECEPTOR ANTAGONISTS | TEIJIN LTD (JP) | 2001-11-21 | — | — | EP | disclosed |
| EP-0071543-B1 | PIPERAZINE DERIVATIVES OF THEOBROMINE | LABORATOIRES SYNTEX (FR) | 1987-10-21 | — | — | EP | disclosed |
| US-4374837-A | ANTIHISTAMINES | LAROCHE NAVARRON, S.A. (US) | 1983-02-22 | — | — | US | disclosed |
| EP-0071543-A1 | Piperazine derivatives of theobromine | LABORATOIRES SYNTEX (FR) | 1983-02-09 | — | — | EP | disclosed |
| JP-S5640685-A | PREPARATION OF THEOBROMINE DERIVATIVE | MARUKO SEIYAKU KK | 1981-04-16 | — | — | JP | disclosed |
| JP-S5576876-A | PREPARATION OF 1-(OXOALKYL)-3,7-DIMETHYLXANTHINE DERIVATNE | GRELAN PHARMACEUT CO LTD | 1980-06-10 | — | — | JP | disclosed |
| JP-S5562087-A | PREPARATION OF 1-(3-CHLOROPROPYL)-3, 7-DIMETHYLXANTHINE | GRELAN PHARMACEUT CO LTD | 1980-05-10 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117148-A1 | SEMICONDUCTOR TREATMENT LIQUID, TREATMENT METHOD FOR OBJECT TO BE TREATED, AND MANUFACTURING METHOD OF ELECTRONIC DEVICE | TPMT, P2RY13, TST | ADORA2B 689/4885TNF 119/4885ACHE 1598/4885 |
| US-20250017209-A1 | COMPOSITION, MANUFACTURING METHOD FOR SEMICONDUCTOR ELEMENT, AND CLEANING METHOD FOR SEMICONDUCTOR SUBSTRATE | SPOUT1, SRM, SMOX | ADORA2B 3037/4885TNF 829/4885ACHE 294/4885 |
| US-20090270369-A1 | BICYCLOAMINE DERIVATIVES | SCN1B, KCNJ2, KCNH2 | ADORA2B 970/4885TNF 3933/4885ACHE 600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.